{"product_id":"2023-portugal-cancer-diagnostics-market-2022-supplier-shares-and-strategies-2022-2027-volume-and-sales-segment-forecasts-for-over-40-individual-tumor-markers","title":"2023 Portugal Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers","description":"\u003cp\u003e2023 Portugal Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers\u003c\/p\u003e \n\n\u003cp\u003eThis unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source, including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products by test.\u003c\/p\u003e\n\n\u003cp\u003eACTH, AFP, Beta-2 Microglobulin, CA 15-3\/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.\u003c\/p\u003e\n\n\u003cp\u003eThe companies analyzed in this report include:\u003c\/p\u003e\n\n\u003cp\u003eAbbott\u003cbr\u003e\nAgilent Technologies\u003cbr\u003e\nApplied Gene Technologies\u003cbr\u003e\nArca Biopharma\u003cbr\u003e\nBeckman Coulter\/Cepheid\/Danaher\u003cbr\u003e\nBecton Dickinson\u003cbr\u003e\nbioMerieux\u003cbr\u003e\nBio-Rad\u003cbr\u003e\nCellSearch\u003cbr\u003e\nClinical Genomics\u003cbr\u003e\nDecode Genetics\u003cbr\u003e\nDiaSorin\u003cbr\u003e\nDiazyme\u003cbr\u003e\nEiken Chemical\u003cbr\u003e\nElitech Group\u003cbr\u003e\nEnzo Biochem\u003cbr\u003e\nEpigenomics\u003cbr\u003e\nErba Mannheim\u003cbr\u003e\nExact Sciences\u003cbr\u003e\nFujifilm Wako\u003cbr\u003e\nFujirebio\u003cbr\u003e\nGrifols\u003cbr\u003e\nGSK\u003cbr\u003e\nGuided Therapeutics\u003cbr\u003e\nHologic\u003cbr\u003e\nJanssen Diagnostics\u003cbr\u003e\nKyowa Medex\u003cbr\u003e\nLabcorp\u003cbr\u003e\nLeica Biosystems\u003cbr\u003e\nLonza\u003cbr\u003e\nMyriad Genetics\u003cbr\u003e\nOncoLab\u003cbr\u003e\nOrtho-Clinical Diagnostics\u003cbr\u003e\nPerkinElmer\u003cbr\u003e\nPolymedco\u003cbr\u003e\nQiagen\u003cbr\u003e\nQuest Diagnostics\u003cbr\u003e\nRoche\u003cbr\u003e\nScienion\u003cbr\u003e\nSiemens Healthineers\u003cbr\u003e\nTakara Bio\u003cbr\u003e\nTheradiag\u003cbr\u003e\nThermo Fisher\u003cbr\u003e\nTosoh\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ - \/ MCW16226001","offer_id":47645824155954,"sku":null,"price":1140.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/2023-portugal-cancer-diagnostics-market-2022-supplier-shares-and-strategies-2022-2027-volume-and-sales-segment-forecasts-for-over-40-individual-tumor-markers","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}